1. Home
  2. SYBX vs GDHG Comparison

SYBX vs GDHG Comparison

Compare SYBX & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • GDHG
  • Stock Information
  • Founded
  • SYBX N/A
  • GDHG 2008
  • Country
  • SYBX United States
  • GDHG China
  • Employees
  • SYBX N/A
  • GDHG N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • SYBX Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • SYBX Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • SYBX 16.4M
  • GDHG 19.4M
  • IPO Year
  • SYBX N/A
  • GDHG 2023
  • Fundamental
  • Price
  • SYBX $1.46
  • GDHG $0.40
  • Analyst Decision
  • SYBX
  • GDHG
  • Analyst Count
  • SYBX 0
  • GDHG 0
  • Target Price
  • SYBX N/A
  • GDHG N/A
  • AVG Volume (30 Days)
  • SYBX 53.6K
  • GDHG 858.7K
  • Earning Date
  • SYBX 08-07-2025
  • GDHG 07-11-2025
  • Dividend Yield
  • SYBX N/A
  • GDHG N/A
  • EPS Growth
  • SYBX N/A
  • GDHG N/A
  • EPS
  • SYBX N/A
  • GDHG N/A
  • Revenue
  • SYBX N/A
  • GDHG $16,666,899.00
  • Revenue This Year
  • SYBX N/A
  • GDHG N/A
  • Revenue Next Year
  • SYBX N/A
  • GDHG N/A
  • P/E Ratio
  • SYBX N/A
  • GDHG N/A
  • Revenue Growth
  • SYBX N/A
  • GDHG N/A
  • 52 Week Low
  • SYBX $0.90
  • GDHG $0.16
  • 52 Week High
  • SYBX $1.96
  • GDHG $168.75
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 52.54
  • GDHG 34.33
  • Support Level
  • SYBX $1.33
  • GDHG $0.33
  • Resistance Level
  • SYBX $1.67
  • GDHG $0.44
  • Average True Range (ATR)
  • SYBX 0.12
  • GDHG 0.11
  • MACD
  • SYBX -0.01
  • GDHG 0.04
  • Stochastic Oscillator
  • SYBX 38.24
  • GDHG 43.19

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: